110 studies found for:    dengue
Show Display Options
Rank Status Study
61 Active, not recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
62 Completed Evaluation of the Safety and Immune Response of Five Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine-Admixture 1;   Biological: TetraVax-DV Vaccine-Admixture 2;   Biological: TetraVax-DV Vaccine-Admixture 3;   Biological: TetraVax-DV Vaccine-Admixture 4;   Biological: Placebo;   Biological: TetraVax-DV Vaccine-Admixture 5
63 Recruiting Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Other: Supportive care
64 Completed Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults
Condition: Dengue Fever
Intervention: Biological: rDEN3delta30/31‐7164
65 Active, not recruiting Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease
Condition: Dengue Fever
Interventions: Biological: DENV-1 PIV,  2.5 µg;   Biological: DENV-1 PIV,  5 µg
66 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)
Condition: Dengue Fever
Interventions: Biological: Biological/Vaccine: 4 µg TDENV-PIV with Alum adjuvant;   Biological: Biological/Vaccine: 1 µg TDENV-PIV with AS03B adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E adjuvant
67 Active, not recruiting Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV003;   Biological: rDEN2∆30-7169;   Biological: Placebo
68 Completed Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus
Conditions: Dengue Shock Syndrome;   Dengue Hemorrhagic Fever
Interventions: Biological: DEN4 Vaccine Candidate;   Biological: DEN4 Vaccine Placebo
69 Unknown  Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
70 Active, not recruiting A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults
Condition: Dengue Fever
Interventions: Biological: 4 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS03B1 adjuvant;   Other: Phosphate buffered saline;   Biological: 1 µg TDENV-PIV with Alum adjuvant;   Biological: 1 µg TDENV-PIV with AS01E1 adjuvant
71 Completed A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand
Condition: Dengue
Interventions: Biological: T-DEN F17;   Biological: T-DEN F-19;   Other: Placebo Control
72 Unknown  Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)
Condition: Dengue Shock Syndrome
Interventions: Drug: Hypertonic sodium lactate;   Drug: Ringer's lactate
73 Withdrawn Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection
Condition: Dengue
Intervention: Genetic: dengue fever
74 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A
75 Active, not recruiting Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Condition: Dengue Fever
Interventions: Drug: Study Drug 1;   Drug: TDV Study Drug 2;   Drug: Study Drug 3;   Drug: TDV Placebo
76 Completed Role of Andi-d in Dengue Fever: a Pilot Study
Condition: Dengue Fever
Intervention: Drug: anti-d
77 Not yet recruiting Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Conditions: Dengue;   Disease Progression
Intervention: Other: diagnostic bedside ultrasound
78 Completed Clinical Specimens Testing Program of Dengue Antigen Detection Reagents
Condition: Dengue Fever
Intervention:
79 Recruiting Evaluation of the Safety and Efficacy of a Single Dose of a Dengue Vaccine (TV005) in Healthy Adults
Condition: Dengue
Interventions: Biological: TV005;   Biological: Placebo;   Biological: rDEN2∆30-7169
80 Completed Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever
Conditions: Acquired Bleeding Disorder;   Dengue Haemorrhagic Fever
Interventions: Drug: activated recombinant human factor VII;   Drug: placebo

First Page    Show previous page of results Previous Page (41-60) Studies Shown (61-80) Next Page (81-100) Show next page of results    Last Page
Indicates status has not been verified in more than two years